Mitoxantrone loaded superparamagnetic nanoparticles for drug targeting: A versatile and sensitive method for quantification of drug enrichment in rabbit tissues using HPLC-UV

Journal of Biomedicine and Biotechnology

Volumn 2010, Issue , 2010, Pages

  Tietze, Rainer ^a   Schreiber, Eveline ^a   Lyer, Stefan ^a   Alexiou, Christoph ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MAGNETIC NANOPARTICLE; MITOXANTRONE; SUPERPARAMAGNETIC NANOPARTICLE; UNCLASSIFIED DRUG; MAGNETITE; NANOPARTICLE; SOLVENT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG STRUCTURE; DRUG TARGETING; DRUG TISSUE LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; KIDNEY PARENCHYMA; LIVER PARENCHYMA; LUNG PARENCHYMA; MUSCLE TISSUE; NONHUMAN; RABBIT; SWINE; ULTRAVIOLET RADIATION; VALIDATION PROCESS; ANIMAL; CHEMISTRY; DRUG DELIVERY SYSTEM; DRUG STABILITY; FRACTIONATION; KIDNEY; LIVER; LUNG; METHODOLOGY; MUSCLE; PILOT STUDY; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; TISSUE DISTRIBUTION;

ORYCTOLAGUS CUNICULUS;

ANIMALS; CHEMICAL FRACTIONATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG DELIVERY SYSTEMS; DRUG STABILITY; FERROSOFERRIC OXIDE; KIDNEY; LIVER; LUNG; MITOXANTRONE; MUSCLES; NANOPARTICLES; PILOT PROJECTS; RABBITS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SOLVENTS; SWINE; TISSUE DISTRIBUTION;

EID: 77953486356     PISSN: 11107243     EISSN: 11107251     Source Type: Journal    
DOI: 10.1155/2010/597304     Document Type: Article

References (25)

1. Jurgons R., Seliger C., Hilpert A., Trahms L., Odenbach S., Alexiou C., Drug loaded magnetic nanoparticles for cancer therapy Journal of Physics Condensed Matter 2006 18 38 S2893 S2902
2. Alexiou C., Jurgons R., Seliger C., Brunke O., Iro H., Odenbach S., Delivery of superparamagnetic nanoparticles for local chemotherapy after intraarterial infusion and magnetic drug targeting Anticancer Research 2007 27 4 2019 2022
3. Alexiou C., Arnold W., Klein R. J., Locoregional cancer treatment with magnetic drug targeting Cancer Research 2000 60 23 6641 6648
4. Alexiou C., Jurgons R., Seliger C., Iro H., Medical applications of magnetic nanoparticles Journal of Nanoscience and Nanotechnology 2006 6 9-10 2762 2768
5. Fox M. E., Smith P. J., Long-term inhibition of DNA synthesis and the persistence of trapped topoisomerase II complexes in determining the toxicity of the antitumor DNA intercalators mAMSA and mitoxantrone Cancer Research 1990 50 18 5813 5818
6. Kapuscinski J., Darzynkiewicz Z., Condensation of nucleic acids by intercalating aromatic cations Proceedings of the National Academy of Sciences of the United States of America 1984 81 23 7368 7372
7. Faulds D., Balfour J. A., Chrisp P., Langtry H. D., Mitoxantrone. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in the chemotherapy of cancer Drugs 1991 41 3 401 449
8. Fidler J. M., DeJoy S. Q., Gibbons J. J. Jr., Selective immunomodulation by the antineoplastic agent mitoxantrone. I. Suppression of B lymphocyte function Journal of Immunology 1986 137 2 727 732
9. Fidler J. M., DeJoy S. Q., Smith F. R. III, Gibbons J. J. Jr., Selective immunomodulation by the antineoplastic agent mitoxantrone. II. Nonspecific adherent suppressor cells derived from mitoxantrone-treated mice Journal of Immunology 1986 136 8 2747 2754
10. Wiekhorst F., Seliger C., Jurgons R., Quantification of magnetic nanoparticles by magnetorelaxometry and comparison to histology after magnetic drug targeting Journal of Nanoscience and Nanotechnology 2006 6 9-10 3222 3225
11. Seliger C., Jurgons R., Wiekhorst F., In vitro investigation of the behaviour of magnetic particles by a circulating artery model Journal of Magnetism and Magnetic Materials 2007 311 1 358 362
12. Catalin J., Peloux A. F., Coloma F., Direct determination of mitoxantrone in plasma by high performance liquid chromatography using an automatic precolumn-switching system as sample clean-up procedure Biomedical Chromatography 1994 8 1 37 41
13. Slordal L., Andersen A., Warren D. J., A sensitive and simple high-performance liquid chromatographic method for the determination of mitoxantrone in plasma Therapeutic Drug Monitoring 1993 15 4 328 333 (Pubitemid 23237585)
14. Priston M. J., Sewelfe G. J., Improved LC assay for the determination of mitozantrone in plasma: analytical considerations Journal of Pharmaceutical and Biomedical Analysis 1994 12 9 1153 1162
15. Luftensteiner C. P., Schwendenwein I., Paul B., Eichler H. G., Viernstein H., Evaluation of mitoxantrone-loaded albumin microspheres following intraperitoneal administration to rats Journal of Controlled Release 1999 57 1 35 44
16. Lin K. T., Rivard G. E., Leclerc J.-M., High-performance liquid chromatographic determination of mitoxantrone in plasma utilizing non-bonded silica gel for solid-phase isolation to reduce adsorptive losses on glass during sample preparation Journal of Chromatography 1989 465 1 75 86
17. Rentsch K. M., Schwendener R. A., Hanseler E., Determination of mitoxantrone in mouse whole blood and different tissues by high-performance liquid chromatography Journal of Chromatography B 1996 679 1-2 185 192
18. Johnson J. L., Ahmad A., Khan S., Improved liquid chromatographic method for mitoxantrone quantification in mouse plasma and tissues to study the pharmacokinetics of a liposome entrapped mitoxantrone formulation Journal of Chromatography B 2004 799 1 149 155
19. Lu B., Xiong S.-B., Yang H., Yin X.-D., Zhao R.-B., Mitoxantrone-loaded BSA nanospheres and chitosan nanospheres for local injection against breast cancer and its lymph node metastases. II: tissue distribution and pharmacodynamics International Journal of Pharmaceutics 2006 307 2 175 181 (Pubitemid 41820411)
20. Hodenius M., Polymer- und liposomstabilisierte ferrofluide und ihre funktionalisierung, Ph.D. thesis 2002 Fakultt fr Mathematik, Informatik und Naturwissenschaften
21. FDA, Guidance for Industry Bioanalytical Method Validation. 2001, http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/ Guidances/ucm122858.pdf
22. Wellmitz J., Gluschke M., Leitlinie zur Methodenvalidierung. 05-01, 2005
23. Klejdus B., Vacek J., Adam V., Determination of isoflavones in soybean food and human urine using liquid chromatography with electrochemical detection Journal of Chromatography B 2004 806 2 101 111
24. Moreno F. J., Olano A., Santa-Maria G., Corzo N., Determination of maltodextrins in enteral formulations by three different chromatographic methods Chromatographia 1999 50 11-12 705 710
25. Shabir G. A., Validation of high-performance liquid chromatography methods for pharmaceutical analysis: understanding the differences and similarities between validation requirements of the US Food and Drug Administration, the US Pharmacopeia and the International Conference on Harmonization Journal of Chromatography A 2003 987 1-2 57 66